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Aims Neutrophils/platelet interactions are involved in abdominal aortic aneurysm (AAA). The intralum-
inal thrombus (ILT) is a human model of platelet/neutrophil interactions. The present study focused on
mediators involved in neutrophil recruitment in AAA.
Methods and results Conditioned media from luminal, intermediate, and abluminal layers of 29 human
ILTs were analysed for neutrophil markers [elastase/a1-antitrypsin and MMP9/NGAL complexes, myelo-
peroxidase (MPO), and a-defensin peptides], RANTES, platelet factor 4 (PF4), and interleukin-8 (IL-8).
Their time-dependent release into serum from clots generated in vitro and their plasma concentrations
in AAA patients and controls were determined. Immunohistochemistry for neutrophils, platelets, IL-8,
PF4, and RANTES on AAA sections was performed; and molecules involved in ILT neutrophil chemotactic
function were analysed in vitro. Neutrophils and platelets colocalized in the luminal layer of the throm-
bus. Consistently, neutrophil markers and platelet-derived RANTES and PF4 were released predomi-
nantly by the luminal thrombus pole, where their concentrations were signiﬁcantly correlated. The
luminal ILT layer was also the main source of IL-8, whose immunostaining colocalized with neutrophils.
All were also released time dependently from clots and were increased in plasma of AAA patients.
Luminal ILT layers displayed potent neutrophil chemotactic activity in vitro, which was inhibited by
RANTES- and IL-8-blocking antibodies as well as by reparixin, an antagonist of the IL-8 receptors
CXCR1 and CXCR2.
Conclusion Taken together, these results suggest that platelet-derived RANTES and neutrophil-derived
IL-8 are involved in attracting neutrophils to the luminal layer of AAA ILT.
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1. Introduction
Progressive dilatation of the aortic wall in abdominal aortic
aneurysm (AAA) is associated with extracellular matrix
breakdown.
1 Such tissue-degrading remodelling involves
proteolytic enzymes whose levels are increased in AAA.
2,3
Neutrophils produce large amounts of proteases, and
recent experimental studies in mice have pointed out the
determinant role of neutrophils in AAA development.
4–6 In
AAA, neutrophils are mainly found within the luminal layer
of the non-occlusive intraluminal thrombus (ILT) that
develops at the interface with the circulating blood,
7,8 and
leucocyte elastase prevents ILTrecolonization by mesenchy-
mal cells.
9
Morphological characteristics of the thrombus
10,11 are
linked to the risk of rupture;
12,13 and more degradation is
observed in the part of the aneurysmal wall lined by a
thrombus than in the adjacent part in contact with the
ﬂowing blood,
14 indirectly suggesting a role of ILT in AAA
pathology. ILT stores large amounts of proteases,
8,15–17
including neutrophil-derived proteases.
7–9 Interestingly,
inhibition of platelet aggregation or activation limited
aneurysmal enlargement
18–20 and was associated with a
reduced accumulation of neutrophils within the thrombus,
suggesting links between platelet activation and neutrophil
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produce neutrophil chemotactic factors, including
interleukin-8 (IL-8)
21 may amplify their own recruitment.
22
The present study aims at investigating molecular
mediators involved in ILT neutrophil recruitment. For this
purpose, we explored the topological distribution of
neutrophil- and platelet-derived chemokines IL-8, RANTES,
and platelet factor 4 (PF4) in the ILT and wall of human
AAAs by immunohistochemical and biochemical approaches.
This was completed by the measurement of the release of
neutrophil markers, IL-8, RANTES, and PF4 into serum
during blood clot retraction and lysis in vitro. Related-
plasma levels in AAA patients and healthy controls were
determined. Finally, the study assessed the neutrophil che-
motactic activity of ILT tissue-culture media ex vivo and
the involvement of IL-8 and RANTES in this phenomenon.
2. Methods
2.1. Plasma and tissue samples
Blood was collected 24 h before surgery on sodium citrate
from 24 patients (male, aged 69.6+8.7 years, range 60–
82) with degenerative AAA,
20 and 24 healthy male controls
(aged 68.7+8.5 years, range 58–78) examined at ‘Centre
d’Investigation Preventative et Clinique’ (IPC, Paris).
23 A sig-
niﬁcant ILT was present in all the AAA studied. Circulating
aortic channels were measured at the level of maximal dila-
tation on CTscan. ILT proportion was calculated as followed:
(maximal aortic diameter2circulating channel)/maximal
aortic diameter and was expressed as percentage. The
mean maximal AAA diameter was 54.0+8.55 mm. The
mean ILT thickness was 25.5+8.4 mm, representing
46.8+11.8% of the AAA dilatation.
Samples of AAA thrombus and residual wall were obtained
during AAA surgical repair from these 24 and ﬁve additional
patients. ILT (n ¼ 29) were dissected into luminal, inter-
mediate, and abluminal layers
9,20 and the wall was separ-
ated into media and adventitia (n ¼ 10). The thrombus
layers, media, and adventitia were cut into small pieces
(1 mm
3) and separately incubated in RPMI-1640 medium
(Gibco) for 24 h at 378C (2 ml/g wet tissue). The tissue-
culture media containing released material were then col-
lected and stored at 2808C after determining the protein
concentration by the Bradford assay (Bio-Rad). Ethics Com-
mittee advice and patient and healthy volunteer informed
consent were obtained (RESAA and AMETHYST studies, CPP
Paris-Cochin no 2095, 1930, and 1931). The investigation
conforms with the principles outlined in the Declaration of
Helsinki.
In vitro serum from three healthy volunteers was obtained
2 h and 1, 2, 3, 4, and 7 days after clotting of blood at 378C.
Paired citrated plasma samples were used directly or recal-
ciﬁed (3 10
22 M CaCl2) to induce ﬁbrin formation in the
absence of blood cells. Sera, plasma, and recalciﬁed
plasma were then kept at 2808C until ELISAs were
performed.
2.2. Imunohistochemistry
AAA samples (n ¼ 8) were ﬁxed in 3.7% paraformaldehyde,
embedded in parafﬁn, and sectioned at 5 mm. Immunohisto-
chemistry was performed using anti-IL-8 (dilution 1:50,
Santa Cruz Biotechnologies), anti-RANTES (dilution 1:5,
R&D Systems), anti-PF4 (dilution 1:100, Abcam), anti-NGAL
(dilution 1:100, Hycult), anti-proteinase-3 (dilution 1:50,
Hycult), anti-CD66b (neutrophils, dilution 1:25, Immuno-
tech), anti-CD68 (macrophages, dilution 1:50, Dako),
anti-CD41 (integrin aIIb, platelets, dilution 1:100, Santa
Cruz Biotechnologies), anti-CD3 (T-lymphocytes, dilution
1:10, Dako), and anti-CD20 (B-lymphocytes, dilution 1:100,
Dako) as primary antibodies and a peroxidase Dako LSAB
kit for detection. Control irrelevant antibodies (Dako)
were applied at the same concentration in order to assess
non-speciﬁc staining.
2.3. ELISA tests
Concentrations of MPO (Hycult), a-defensins (Hycult), elas-
tase/a1-antitrypsin complexes (Calbiochem), IL-8 (R&D
Systems and Sanquin), RANTES (R&D Systems), MMP-9/
NGAL complexes (R&D Systems), and PF4 (American Diagnos-
tica) were determined by ELISA kits, according to the man-
ufacturers’ instructions. For intra- and inter-assay
coefﬁcients of variation, see Supplementary material
online, TableS1.
2.4. Neutrophil chemotaxis assay
Neutrophils were obtained from heparinized venous blood of
volunteers by sedimentation on a separating medium con-
taining 9% Dextran T500 (Pharmacia LKB, Uppsala,
Sweden) and 38% Radioselectan (Schering, Lannoy,
France). After two washes in phosphate buffered saline
(PBS), neutrophils were counted on a Hemalog H1 device
(Technicon Instruments Corporation, Tarrytown, NY, USA)
and adjusted to 10
5 neutrophils/mL in PBS.
Neutrophil chemotaxis was determined according to
Vicioso et al.
24 Eight series of three, star-shaped wells,
24 mm in diameter and 24 mm apart were cut in agarose
plates [0.7% agarose (Indubiose A37, BioSepra,
Villeneuve-La-Garenne, France) in Kreb’s buffer pH 6.8 con-
taining 10% foetal calf serum (Bio Whittacker, Lagny,
France)]. The centre well of each three-well series received
5 mL of neutrophil suspension. The outer well received 5 mL
of chemotactic factor, i.e. formyl-methionyl-leucyl-
phenylalanine (10
27 M, fMLP, Sigma), recombinant human
IL-8 (20 ng/mL, R&D Systems), recombinant human RANTES
(0.1 mg/mL, R&D Systems), or thrombus luminal and ablum-
inal conditioned media. In some experiments, conditioned
media of luminal thrombus, IL-8, and RANTES were pre-
treated with 0.1 mg/mL human IL-8 (R&D Systems),
RANTES (R&D Systems) blocking antibodies (n ¼ 6), or neu-
trophils were incubated with reparixin (10
26 M, generously
provided by Dompe ´ pharma, Italy) (n ¼ 7), a speciﬁc non-
competitive allosteric inhibitor of CXCR1 and CXCR2 recep-
tors,
25 for 20 min at room temperature. The inner well
received 5 mL of RPMI-1640 as a non-chemotactic control
of spontaneous migration. The dishes were incubated at
378C in a humidiﬁed 5% CO2 incubator for 4 h, and migration
was quantiﬁed using an inverted microscope with an ocular
micrometer, by measuring (in millimetres) the linear dis-
tances the cells had moved from the margin of the wells
towards the chemotactic factor (oriented migration) and
the control medium (spontaneous migration). Results
were expressed as a ‘chemotactic differential’ (oriented
migration2spontaneous migration).
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Results are expressed as mean+SD. The paired Wilcoxon
and Mann–Whitney non-parametric tests (Statview soft-
ware, version 4.57) were used to compare the results
between each AAA compartment of the same sample and
between AAA and control plasma, respectively. Results are
presented as box plots, in which the median is shown.
Upper and lower limits of boxes represent inter-quartiles
(25th and 75th), whereas upper and lower bars show percen-
tiles (10th and 90th). Correlations were established by
Spearman’s rank test. Statistical signiﬁcance was accepted
for P , 0.05.
3. Results
3.1. Neutrophil distribution in abdominal aortic
aneurysm
Neutrophils, revealed by positive immunostaining of CD66b,
NGAL, and proteinase-3, were detected within the most
luminal part (blood interface layer) of the ILT and in the
adventitia (Figure 1A). No neutrophils were detected
within the deeper thrombus layers (Figure 1A, insets).
Consistently, soluble neutrophil markers measured by
ELISA, i.e. elastase/a1-antitrypsin, MMP9/NGAL, MPO, and
a-defensins, were all essentially found in supernatants of
the luminal ILT layer with a signiﬁcant negative gradient
from the luminal to the abluminal poles (Figure 1B–E). Sig-
niﬁcant positive correlations were found between all these
neutrophil markers released by the ILT luminal pole,
whereas only a-defensins signiﬁcantly correlated with
maximal ILT thickness (Table 1).
3.2. Interleukin-8 distribution in abdominal aortic
aneurysm
A negative gradient from the luminal to the abluminal ILT
layer was observed, with signiﬁcantly more IL-8 released
by the luminal layer (Figure 2A). IL-8-positive staining was
associated with neutrophils present at the luminal pole,
whereas no staining was detected in deeper thrombus
layers (Figure 2B). Moreover, IL-8 released by ILT strongly
correlated with elastase/a1-antitrypsin, MMP9/NGAL, MPO,
and a-defensins, but it did not with maximal aortic diameter
and ILT thickness (Table 1). Aneurysmal media and adventi-
tia also released IL-8, and concentrations in the adventitia
were similar to those in the luminal ILT layer (Figure 2A).
However, the total amount of IL-8 released by ILTwas four-
fold higher when compared with the wall (1830+325 and
Figure 1 Release of neutrophil markers by abdominal aortic aneurysm compartments and immunolocalization of neutrophils in abdominal aortic aneurysm. (A)
Within the thrombus (n ¼ 8), neutrophil CD66b and neutrophil-derived NGAL and proteinase-3 staining were detected at the luminal pole, whereas no staining
was observed in deeper layers, devoid of cells (insets). Within the wall (n ¼ 8), CD66b-positive staining was observed in the adventitia. NGAL and proteinase-3
staining were associated with CD66b within the adventitia. Negative controls for luminal thrombus layer and adventitia. Bar ¼ 100 mm. Photomicrographs pre-
sented are representative of all tissues analysed. (B–E) Conditioned media from luminal, intermediate, and abluminal layers of abdominal aortic aneurysm
thrombi (n ¼ 29) and from the medial layer and adventitia of the remaining wall (n ¼ 10) were analysed by ELISA for elastase/a1-antitrypsin complexes (B), mye-
loperoxidase (C), MMP9/NGAL complexes (D), and a-defensins (E). All these markers were predominantly released by the thrombus where a negative gradient
from the luminal to the abluminal pole was found.
‡P , 0.05, *P , 0.01, **P , 0.001, and ***P , 0.0001.
X. Houard et al. 534459+84 ng for ILT and the wall, respectively, P , 0.01),
taking into account the weight difference between them.
Within the wall, IL-8 staining was found in macrophage-
and neutrophil-positive areas of the adventitia (Figure 2B).
3.3. RANTES and platelet factor 4 distribution in
abdominal aortic aneurysm
A similar distribution pattern was observed for RANTES and
PF4 (Figure 3A and B). The luminal layer released
Table 1 Correlations between neutrophil and platelet markers and interleukin-8 released by the thrombus, maximal aortic diameter, and
intraluminal thrombus thickness
Elastase/a1-antitrypsin
complexes
MPO MMP9/NGAL
complexes
a-Defensins IL-8 RANTES PF4
MPO r ¼ 0.670
P , 0.001
MMP9/NGAL
complexes
r ¼ 0.838 r ¼ 0.587
P , 0.0001 P , 0.001
a-Defensins r ¼ 0.462 r ¼ 0.347 r ¼ 0.609
P , 0.05 P , 0.01 P , 0.05
IL-8 r ¼ 0.892 r ¼ 0.834 r ¼ 0.896 r ¼ 0.765
P , 0.003 P , 0.02 P , 0.006 P , 0.03
RANTES r ¼ 0.784 r ¼ 0.577 r ¼ 0.690 r ¼ 0.170 r ¼ 0.783
P , 0.001 P , 0.003 P , 0.0001 P ¼ 0.8 P , 0.001
PF4 r ¼ 0.641 r ¼ 0.425 r ¼ 0.599 r ¼ 0.190 r ¼ 0.838 r ¼ 0.811
P , 0.0001 P , 0.01 P , 0.001 P ¼ 0.6 P , 0.003 P , 0.0001
Maximal aortic
diameter
r ¼ 0.228 r ¼ 0.3636 r ¼ 0.089 r ¼ 0.114 r ¼ 0.167 r ¼ 0.408 r ¼ 0.230
P ¼ 0.8 P ¼ 0.4 P ¼ 0.7 P ¼ 0.06 P ¼ 0.5 P ¼ 0.8 P ¼ 0.6
Maximal ILT
thickness
r ¼ 0.486 r ¼ 0.459 r ¼ 0.252 r ¼ 0.413 r ¼ 0.371 r ¼ 0.262 r ¼ 0.370
P ¼ 0.2 P ¼ 0.2 P ¼ 0.7 P , 0.01 P ¼ 0.5 P ¼ 0.8 P ¼ 0.7
Figure 2 Interleukin-8 (IL-8) release by abdominal aortic aneurysm compartments and immunolocalization. (A) Conditioned media from luminal, intermediate,
and abluminal layers of abdominal aortic aneurysm thrombi (n ¼ 29) and from media and adventitia of the wall (n ¼ 10) were analysed for interleukin-8 antigen
by ELISA. Interleukin-8 antigen was found in supernatants of all compartments.
‡P , 0.05 vs. intermediate, *P , 0.01 vs. media and adventitia and **P , 0.001 vs.
abluminal. (B) Immunohistochemical staining of interleukin-8. Within the thrombus (n ¼ 8), interleukin-8 accumulated at the luminal pole, whereas no staining
was observed in deeper layers (inset). At the luminal pole, interleukin-8 staining colocalized with CD66b-positive neutrophils. Note the absence of macrophages
in the luminal part of the thrombus. In adventitia (n ¼ 8), interleukin-8 staining was observed in neutrophil- and macrophage-rich areas. Bar ¼ 100 mm. Photo-
micrographs presented are representative of all tissues analysed.
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or the media and adventitia. In addition, a strong positive
correlation was found between the two chemokines in the
tissue-culture media from the luminal ILT pole (Table 1).
Moreover, RANTES and PF4 immunostaining colocalized
within the ILT, where they were associated, at the
luminal pole, with platelet immunoreactivity revealed by
CD41-positive staining, consistent with their platelet
origin (Figure 3C). Interestingly, platelets and neutrophils
colocalized in the luminal layer of the thrombus
(Figure 3C), and strong positive correlations were found
for both RANTES and PF4 and with elastase/a1-antitrypsin,
MMP9/NGAL, and MPO or IL-8 (Table 1). In contrast,
RANTES and PF4 did not correlate with a-defensin levels
or maximal aortic diameter and ILT thickness. Within the
wall, RANTES and PF4 staining was localized in
lymphocyte-rich areas of the adventitia, whereas platelets
were not observed (Figure 3C). In such areas, IL-8-positive
staining was present, as well as some neutrophils
(Figure 3C).
3.4. Release of neutrophil markers, interleukin-8,
RANTES, and platelet factor 4 in sera during
clot lysis
Neutrophil markers, IL-8, RANTES, and PF4 were found in
higher concentrations in serum from three healthy volun-
teers when compared with paired plasma or plasma-derived
serum (Figure 4). Serum concentrations of elastase/a1-
-antitrypsin, MMP9/NGAL, a-defensins, and RANTES
increased during clot retraction and lysis, reaching their
maximal levels between 24 and 96 h, and then decreased.
In contrast, no decrease in MPO and IL-8 concentration
was observed, whereas maximal serum concentrations of
PF4 were reached as early as 2 h and decreased after 24 h
(Figure 4).
3.5. Neutrophil chemotaxis
Tissue-culture media from both luminal and abluminal
thrombus layers induced neutrophil chemotaxis, with a sig-
niﬁcantly stronger activity displayed by the luminal part
Figure 3 Release of RANTES and platelet factor 4 by abdominal aortic aneurysm compartments and immunolocalization. (A and B) Conditioned media from
luminal, intermediate, and abluminal layers of abdominal aortic aneurysm thrombi (n ¼ 29) and from media and adventitia of the remaining wall (n ¼ 10)
were analysed by ELISA for RANTES (A) and platelet factor 4 (B). Both RANTES and platelet factor 4 were mainly released by the luminal thrombus layer
when compared with other abdominal aortic aneurysm compartments.
‡P , 0.05, *P , 0.01, **P , 0.001, and ***P , 0.0001. (C) Immunolocalization of
RANTES, platelet factor 4, and CD41 within the luminal pole of abdominal aortic aneurysm mural thrombus and adventitia (n ¼ 8). Within intraluminal thrombus,
RANTES, and platelet factor 4 were observed at the luminal pole in ﬁbrin rich-areas and colocalized with platelet CD41 staining. Note the colocalization of plate-
let CD41- and neutrophil CD66b-positive staining at the luminal pole of intraluminal thrombus. Within the diseased wall, no staining was detected for CD41.
RANTES and platelet factor 4 were localized in CD3- and CD20-positive areas within the adventitia, where interleukin-8-positive staining was also observed.
Some neutrophils can be found in such areas. Bar ¼ 100 mm. Photomicrographs presented are representative of all tissues analysed.
X. Houard et al. 536(Figure 5A). A 50% inhibition of the neutrophil chemotaxis
induced by the ILT luminal pole was obtained with
IL-8-blocking antibody and reparixin, an inhibitor of IL-8
receptors,
25 as well as with RANTES-blocking antibody
(Figure 5B).
3.6. Plasma concentrations of neutrophil markers
in abdominal aortic aneurysm patients
Elevated-plasma concentrations of the four neutrophil
markers (elastase/a1-antitrypsin, MPO, MMP9/NGAL, and
a-defensins) were found in AAA patients against healthy
controls (Figure 6). In AAA plasma, strong association was
found between levels of each neutrophil markers
(Table 2). IL-8, RANTES, and PF4 plasma levels were also
increased in AAA patients (Figure 6), but did not reach stat-
istical signiﬁcance for IL-8. Interestingly, plasma concen-
trations of platelet PF4 and RANTES were correlated,
suggesting the platelet origin of RANTES in plasma
(Table 2). Plasma levels of neutrophil markers in AAA
patients were strongly correlated with platelet PF4 and
RANTES, whereas IL-8 levels were correlated with RANTES,
PF4, and the neutrophil markers, elastase/a1-antitrypsin
and a-defensins (Table 2). In contrast, plasma levels of neu-
trophil and platelet markers did not correlate with either
maximal aortic diameter or maximal ILT thickness,
whereas IL-8 plasma levels correlated with maximal aortic
diameter (Table 2). Similarly, no correlation was found
between plasma levels of these markers and their concen-
trations in tissue conditioned media.
4. Discussion
The contribution of neutrophils to AAA evolution has been
recently highlighted by studies showing that neutropenia
limited AAA development after elastase perfusion in
mice,
4 whereas L-selectin
5 or dipeptidyl peptidase I
deﬁciencies
6 prevented both neutrophil recruitment and
murine AAA development. Although neutrophils are
present in aneurysmal adventitia (Cohen et al.
26 and the
present study), neutrophils predominantly accumulate
within the luminal pole of the ILT
9,20,27 at the interface
with circulating blood. Elastase/a1-antitrypsin, MMP9/
NGAL, MPO, and a-defensins, used as neutrophil markers,
were all essentially released by the luminal ILT layer, as
reported for neutrophil-derived elastase, MMP-8, uPA, and
MMP9/NGAL,
7–9 and strong positive correlations were
found between them.
The interface of ILTwith the ﬂowing blood is also charac-
terized by the presence of activated platelets,
20 involved in
ﬁbrin formation
28 and ILT renewal. The link between ILT
platelet deposition and neutrophil accumulation was
further supported by the presence of P-selectin,
20 the
recently reported correlation between neutrophil-derived
uPA and platelet-derived PAI-1,
8 and by the present data
Figure 4 Time-dependent release of neutrophil markers, interleukin-8, RANTES, and platelet factor 4 from blood clots. Levels of elastase/a1-antitrypsin com-
plexes (A), myeloperoxidase (B), MMP9/NGAL complexes (C), a-defensins (D), interleukin-8 (E), RANTES (F), and platelet factor 4 (G) were measured in serum
after incubation at 378C for 2, 24, 48, 72, 96, and 168 h in plasma (Pl) and recalciﬁed plasma (PlþCaCl2) from three healthy volunteers.
‡P , 0.05, *P , 0.01,
**P , 0.001, and ***P , 0.0001.
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lets within the ILT and the strong positive correlations
between neutrophil markers and RANTES and PF4. RANTES
and PF4 are produced by platelets
29 and were mainly
released by the luminal ILT layer where they colocalized
with CD41 staining. In addition to promoting leucocyte
adhesion via P-selectin expression,
30,31 activated platelets
also release chemokines involved in leucocyte recruitment
to the site of injury, including RANTES and PF4. Tissue-
culture media from the luminal pole of ILT induced neutro-
phil chemotaxis and RANTES-blocking antibody inhibited
50% of neutrophil chemotaxis. Neither puriﬁed PF4 nor
PF4-blocking antibody inﬂuenced neutrophil chemotaxis in
our experiments (data not shown). Conﬂicting results have
been reported concerning the neutrophil chemotactic
activity of PF4.
32,33 Interestingly, within the wall, where
no CD41-positive staining was observed, RANTES and PF4
staining were localized in lymphocyte-rich areas of the
adventitia, consistent with their expression by T-
lymphocytes
34,35 and the reported overexpression of
RANTES in AAA wall.
36 In such areas, some neutrophils can
be found, supporting a role of RANTES in neutrophil
attraction.
IL-8 is a potent neutrophil chemotactic factor whose over-
expression in human AAA
36–38 has been reported. Our data
conﬁrm these previous results showing IL-8-positive staining
in inﬂammatory areas of the adventitia, rich in neutrophils
and macrophages, and the release of IL-8 into tissue-culture
media from wall compartments. We mainly describe, for the
ﬁrst time, the presence of IL-8 within the ILT, where positive
staining colocalized with neutrophils. Moreover, signiﬁcant
positive correlations were found between IL-8 and neutro-
phil markers released by ILT. Interestingly, IL-8 distribution
in AAA reﬂected the localization of inﬂammation, which
Figure 5 Interleukin-8 and RANTES-dependent neutrophil chemotactic
activity of the luminal thrombus layer. (A) Conditioned media from luminal
and abluminal thrombus layers (n ¼ 29) were tested for their neutrophil che-
motactic ability, as described in Methods section. fMLP (10
27 M) was used as a
positive control for neutrophil chemotaxis. (B) Reparixin (10
26 M) added to
neutrophils (n ¼ 7) or interleukin-8- and RANTES-blocking antibodies added
to conditioned media (n ¼ 6) inhibited neutrophil chemotaxis induced by con-
ditioned media from the luminal layer of the thrombus.
‡P , 0.05 vs. repar-
ixin, interleukin-8, and RANTES-blocking antibodies, **P , 0.001 vs.
abluminal.
Figure 6 Plasma concentrations of neutrophil markers, interleukin-8, RANTES, and platelet factor 4. Levels of elastase/a1-antitrypsin complexes (A), myelo-
peroxidase (B), MMP9/NGAL complexes (C), a-defensins (D), interleukin-8 (E), RANTES (F), and platelet factor 4 (G) were measured in plasma from 24 abdominal
aortic aneurysm patients and 24 healthy controls.
‡P , 0.05, **P , 0.001, and ***P , 0.0001 vs. healthy controls.
X. Houard et al. 538corresponded to neutrophils at the thrombus luminal pole
and predominantly to macrophages within the adventitia.
Although similar concentrations of IL-8 were released in
tissue-culture media from the luminal ILT layer and the
adventitia, four-fold higher amounts of IL-8 were released
by ILT than by the wall, taking into account the weight
difference between them. Thus, ILT is the main source of
IL-8 in the AAA lesion. Consistent with the presence of IL-8
within the ILT, neutrophil chemotactic activity of the
luminal thrombus layer was efﬁciently inhibited by IL-8
blocking antibody and by reparixin, a synthetic antagonist
of IL-8 receptors. Similar to the ILT, blood clots generated
in vitro released, in a time-dependent manner, platelet-
derived RANTES and PF4, as well as the neutrophil markers
and IL-8. This highlights the ability of the thrombus to trap
and activate neutrophils, thus inducing the release of IL-8,
which can amplify neutrophil ILT recruitment.
In spite of the preferential accumulation of platelets and
neutrophils within the thrombus, no correlation between
levels of platelet markers released by the luminal pole and
either maximal aortic diameter or maximal thrombus thick-
ness was observed. This absence of correlation was also
observed for neutrophil markers, with the exception of
a-defensins, whose levels correlated with maximal ILT thick-
ness. This may indicate that cellular and biochemical
markers of the thrombus activities do not parallel its mor-
phological parameters.
Elevated-plasma concentrations of neutrophil and plate-
let markers were observed in AAA patients, as already
described in AAA for markers of platelet activation
20 and
RANTES
39 and in atherosclerosis for neutrophil elastase
40
and PF4.
41 However, plasma concentrations of platelet and
neutrophil markers were not associated with AAA diameter
or ILT thickness, suggesting that plasma levels of these
markers are not directly linked to AAA morphology and
could not be uniquely linked to ILT and AAA wall biological
activities. A link could also exist with peripheral circulating
platelet and neutrophil activation, as recently demon-
strated in aneurysms of the ascending aorta, which are
devoid of any ILT.
42 As reported in coronary artery
disease,
43 increased IL-8 plasma levels were found in AAA
patients compared with controls, but this increase did not
reach statistical signiﬁcance, although IL-8 plasma levels
signiﬁcantly correlated with maximal aortic diameter, as
also previously reported.
44 As observed in tissue-culture
media from the thrombus luminal layer, strong positive cor-
relations were found between plasma concentrations of neu-
trophil markers and platelet-derived RANTES and PF4,
highlighting the relationship between platelet and neutro-
phil activation, whatever tissue or peripheral activation.
Nevertheless, a possible link between plasma and ILTenrich-
ment in neutrophil and platelet markers was supported, at
least in part, by ﬁndings from clots generated in vitro,
showing that serum contains higher amounts of these
markers than plasma, thus demonstrating that clot for-
mation followed by retraction and lysis induces the release
of neutrophil and platelet markers. Therefore, since
elevated-plasma levels of neutrophil and platelet markers
could be related to the accumulation of neutrophil and
platelets within ILT, a contribution of systemic activation
of platelets and leucocytes to these high plasma levels in
AAA patients cannot be excluded.
45,46
In conclusion, the present study shows a preferential
accumulation of neutrophils at the luminal pole of the
mural thrombus and suggests the involvement of platelet-
derived RANTES and neutrophil-derived IL-8 in ILT neutrophil
recruitment. Initiation of neutrophil recruitment may
depend on platelet factors, expressed and released during
ILT formation and renewal, and may be ampliﬁed by IL-8
released from neutrophils. Elevated-plasma concentrations
of platelet and neutrophil markers in AAA patients may
also reﬂect platelet and neutrophil interactions. In view of
this suspected role of platelet/neutrophil interactions,
antagonism of IL-8 and RANTES receptors may represent an
attractive novel strategy to control AAA pathology in human.
Supplementary material
Supplementary material is available at Cardiovascular
Research online.
Table 2 Correlations between plasma concentrations of neutrophil markers, interleukin-8, RANTES, platelet factor 4, and maximal aortic
diameter and intraluminal thrombus thickness in abdominal aortic aneurysm patients
Elastase/a1-antitrypsin
complexes
MPO MMP9/NGAL
complexes
a-Defensins IL-8 RANTES PF4
MPO r ¼ 0.856
P , 0.001
MMP9/NGAL
complexes
r ¼ 0.883 r ¼ 0.824
P , 0.0001 P , 0.0001
a-Defensins r ¼ 0.597 r ¼ 0.763 r ¼ 0.490
P , 0.01 P , 0.05 P , 0.01
IL-8 r ¼ 0.249 r ¼ 0.200 r ¼ 0.195 r ¼ 0.339
P , 0.02 P ¼ 0.2 P ¼ 0.3 P , 0.02
RANTES r ¼ 0.358 r ¼ 0.456 r ¼ 0.293 r ¼ 0.646 r ¼ 0.298
P , 0.01 P , 0.01 P , 0.01 P , 0.01 P , 0.02
PF4 r ¼ 0.549 r ¼ 0.623 r ¼ 0.601 r ¼ 0.566 r ¼ 0.316 r ¼ 0.742
P , 0.001 P , 0.001 P , 0.001 P , 0.01 P , 0.02 P , 0.0001
Maximal aortic
diameter
r ¼ 0.118 r ¼ 0.104 r ¼ 0.138 r ¼ 0 r ¼ 0.588 r ¼ 0.164 r ¼ 0.242
P ¼ 0.7 P ¼ 0.1 P ¼ 0.44 P ¼ 0.5 P , 0.05 P ¼ 0.4 P ¼ 0.3
Maximal ILT
thickness
r ¼ 0.063 r ¼ 0.054 r ¼ 0.063 r ¼ 0.202 r ¼ 0.670 r ¼ 0.031 r ¼ 0.273
P ¼ 0.9 P ¼ 0.9 P ¼ 0.5 P ¼ 0.1 P ¼ 0.055 P ¼ 0.8 P ¼ 0.9
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